Overview

A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain

Status:
Terminated

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to study the efficacy of intravenous administration of ibuprofen compared to placebo in patients with postoperative pain and evaluate its tolerability and safety profile.

Phase:

Phase 3

Details

Lead Sponsor:

Biomendi S.A.U.

Collaborator:

Pivotal S.L.

Treatments:

Ibuprofen
Pharmaceutical Solutions